At week @ , remission rates were similar among treatment arms , but more patients treated with adalimumab @/@ achieved response ( placebo , @ % ; @/@ , @ % ; @/@ , @ % ; P = @ for @/@ vs placebo ) and mucosal healing ( placebo , @ % ; @/@ , @ % ; @/@ , @ % ; P = @ for @/@ vs placebo ) compared with placebo .